MASSAPEQUA, N.Y. and CLEVELAND, April 11 IBF Conferences,Inc., the leading national investment conference organizer, and BioEnterpriseCorporation, the Cleveland-based bioscience business formation, recruitment,and acceleration initiative, are proud to present the 2nd annual GlobalHealthcare Investing Conference. The conference brings together the leading-edge investors, institutions, providers and companies that invest inhealthcare technologies across the world, manage "global" start-ups, andoperate in multiple financial and regulatory markets.

The forum is geared specifically to US and international investors in andentrepreneurs of emerging bioscience companies. The event will be held April29 -- May 1, 2008 in Cleveland, Ohio, and is expected to once again draw over70+ investment firms and 300+ attendees.

This year, company presentations will be at the forefront of theconference. Each presenting company is ex-US or cross-border, and has receivedat least one round of professional funding. These companies span the lifescience industry, including medical devices, diagnostics, drug delivery, drugdiscovery, biotechnology and healthcare information technologies. This year'sselected presenting companies include the following:

This year's conference sponsors have raised the bar on helping securespeakers and presenting companies. 2008's sponsors include: Squire Sanders &Dempsey, LLP; Musculoskeletal Clinical Regulatory Advisers, LLC; UK Trade &Investment; and National City. To learn more about the event and to register,please visit www.globalhealthcareinvesting.com.

About BioEnterprise

BioEnterprise is a business formation, recruitment, and accelerationeffort designed to support the growth of bioscience companies. Located inCleveland, BioEnterprise provides management counsel and support services tohealth care companies. BioEnterprise's partners are Case Western ReserveUniversity, the Cleveland Clinic, University Hospitals, and Summa HealthSystem. Additional technology partners include the NASA Glenn Research Center,Cleveland State University, NorTech and BioOhio.

The initiative comprises the collaborative activities of BioEnterprise andits partners' commercialization offices: the Case Office of TechnologyTransfer, Cleveland Clinic Innovations, University Hospitals Case MedicalCenter -- Center for Clinical Research, and Summa Enterprise Group. Thecombined efforts of these groups has created, recruited, and accelerated morethan 60 companies in four years.

Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished.Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.Full Disclaimer